{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:03:26Z","timestamp":1789538606605,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["(#480-08-009"],"award-info":[{"award-number":["(#480-08-009"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s11764-021-01023-9","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T03:02:56Z","timestamp":1615950176000},"page":"303-313","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Self-perceived cognitive functioning and quality of life among cancer survivors: results from the PROFILES registry"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1595-7262","authenticated-orcid":false,"given":"Simone","family":"Oerlemans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne B.","family":"Schagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina J.","family":"van den Hurk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Husson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dounya","family":"Schoormans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonneke V.","family":"van de Poll-Franse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,17]]},"reference":[{"key":"1023_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3109\/09540261.2013.864260","volume":"26","author":"MC Janelsins","year":"2014","unstructured":"Janelsins MC, Kesler SR, Ahles TA, Morrow GR. Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry. 2014;26:102\u201313.","journal-title":"Int Rev Psychiatry"},{"key":"1023_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/JOM.0b013e3181d0bef7","volume":"52","author":"L Calvio","year":"2010","unstructured":"Calvio L, Peugeot M, Bruns GL, Todd BL, Feuerstein M. Measures of cognitive function and work in occupationally active breast cancer survivors. J Occup Environ Med. 2010;52:219\u201327.","journal-title":"J Occup Environ Med"},{"key":"1023_CR3","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/j.1365-2702.2009.03006.x","volume":"19","author":"F Munir","year":"2010","unstructured":"Munir F, Burrows J, Yarker J, Kalawsky K, Bains M. Women\u2019s perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study. J Clin Nurs. 2010;19:1362\u201370.","journal-title":"J Clin Nurs"},{"key":"1023_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/pon.1581","volume":"19","author":"SA Reid-Arndt","year":"2010","unstructured":"Reid-Arndt SA, Hsieh C, Perry MC. Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer. Psychooncology. 2010;19:535\u201344.","journal-title":"Psychooncology"},{"key":"1023_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/07347330903183117","volume":"27","author":"SA Reid-Arndt","year":"2009","unstructured":"Reid-Arndt SA, Yee A, Perry MC, Hsieh C. Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors. J Psychosoc Oncol. 2009;27:415\u201334.","journal-title":"J Psychosoc Oncol"},{"key":"1023_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/02841860701518058","volume":"47","author":"SB Schagen","year":"2008","unstructured":"Schagen SB, Boogerd W, Muller MJ, ten Bokkel Huinink W, Moonen L, Meinhardt W, et al. Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer. Acta Oncol. 2008;47:63\u201370.","journal-title":"Acta Oncol"},{"key":"1023_CR7","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1001\/jamaoncol.2016.2047","volume":"2","author":"J Savard","year":"2016","unstructured":"Savard J, Ganz PA. Subjective or objective measures of cognitive functioning-what\u2019s more important? JAMA Oncol. 2016;2:1263\u20134.","journal-title":"JAMA Oncol"},{"key":"1023_CR8","first-page":"20","volume":"2","author":"K Gehring","year":"2015","unstructured":"Gehring K, Taphoorn MJ, Sitskoorn MM, Aaronson NK. Predictors of subjective versus objective cognitive functioning in patients with stable grades II and III glioma. Neurooncol Pract. 2015;2:20\u201331.","journal-title":"Neurooncol Pract"},{"key":"1023_CR9","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.ctrv.2012.05.002","volume":"38","author":"AD Hutchinson","year":"2012","unstructured":"Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C. Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat Rev. 2012;38:926\u201334.","journal-title":"Cancer Treat Rev"},{"key":"1023_CR10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.lfs.2013.08.011","volume":"93","author":"MM Cherrier","year":"2013","unstructured":"Cherrier MM, Anderson K, David D, Higano CS, Gray H, Church A, et al. A randomized trial of cognitive rehabilitation in cancer survivors. Life Sci. 2013;93:617\u201322.","journal-title":"Life Sci"},{"key":"1023_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/pon.1878","volume":"21","author":"RJ Ferguson","year":"2012","unstructured":"Ferguson RJ, McDonald BC, Rocque MA, et al. Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial. Psychooncology. 2012;21:176\u201386.","journal-title":"Psychooncology"},{"key":"1023_CR12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s11764-018-0692-x","volume":"12","author":"VJ Bray","year":"2018","unstructured":"Bray VJ, Dhillon HM, Vardy JL. Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment. J Cancer Surviv. 2018;12:537\u201359.","journal-title":"J Cancer Surviv"},{"key":"1023_CR13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s11764-015-0476-5","volume":"10","author":"JE Schmidt","year":"2016","unstructured":"Schmidt JE, Beckjord E, Bovbjerg DH, Low CA, Posluszny DM, Lowery AE, et al. Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey. J Cancer Surviv. 2016;10:302\u201311.","journal-title":"J Cancer Surviv"},{"key":"1023_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/pon.1595","volume":"19","author":"CM Schilder","year":"2010","unstructured":"Schilder CM, Seynaeve C, Linn SC, Boogerd W, Gundy CM, Beex LV, et al. The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy. Psychooncology. 2010;19:415\u201322.","journal-title":"Psychooncology"},{"key":"1023_CR15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/annonc\/mdm500","volume":"19","author":"J Vardy","year":"2008","unstructured":"Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol. 2008;19:623\u20139.","journal-title":"Ann Oncol"},{"key":"1023_CR16","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1093\/arclin\/acx142","volume":"33","author":"JD Clapp","year":"2018","unstructured":"Clapp JD, Luta G, Small BJ, Ahles TA, Root JC, Graham D, et al. The impact of using different reference populations on measurement of breast cancer-related cognitive impairment rates. Arch Clin Neuropsychol. 2018;33:956\u201363.","journal-title":"Arch Clin Neuropsychol"},{"key":"1023_CR17","doi-asserted-by":"publisher","unstructured":"Boscher C, Joly F, Clarisse B, Humbert X, Grellard JM, Binarelli G, et al. Perceived cognitive impairment in breast cancer survivors and its relationships with psychological factors. Cancers (Basel). 2020;12(10):3000. https:\/\/doi.org\/10.3390\/cancers12103000.","DOI":"10.3390\/cancers12103000"},{"key":"1023_CR18","doi-asserted-by":"crossref","unstructured":"Chapman B, Helmrath S, Derakshan N. Perceived cognitive functioning and its influence on emotional vulnerability in breast cancer. Health Psychol Open. 2019;6:2055102919871661.","DOI":"10.1177\/2055102919871661"},{"key":"1023_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejcsup.2014.03.003","volume":"12","author":"SB Schagen","year":"2014","unstructured":"Schagen SB, Klein M, Reijneveld JC, Brain E, Deprez S, Joly F, et al. Monitoring and optimising cognitive function in cancer patients: present knowledge and future directions. EJC Suppl. 2014;12:29\u201340.","journal-title":"EJC Suppl"},{"key":"1023_CR20","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.ejca.2011.04.034","volume":"47","author":"LV van de Poll-Franse","year":"2011","unstructured":"van de Poll-Franse LV, Horevoorts N, van Eenbergen M, Denollet J, Roukema JA, Aaronson NK, et al. The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer. 2011;47:2188\u201394.","journal-title":"Eur J Cancer"},{"key":"1023_CR21","unstructured":"Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S. International classification of diseases for oncology: World Health Organization; 2000."},{"key":"1023_CR22","doi-asserted-by":"crossref","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours, 7th Edition: Wiley; 2011.","DOI":"10.1002\/9780471420194.tnmc26.pub2"},{"key":"1023_CR23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/art.10993","volume":"49","author":"O Sangha","year":"2003","unstructured":"Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49:156\u201363.","journal-title":"Arthritis Rheum"},{"key":"1023_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365\u201376.","journal-title":"J Natl Cancer Inst"},{"key":"1023_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jclinepi.2019.10.003","volume":"118","author":"JM Giesinger","year":"2020","unstructured":"Giesinger JM, Loth FLC, Aaronson NK, Arraras JI, Caocci G, Efficace F, et al. Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research. J Clin Epidemiol. 2020;118:1\u20138.","journal-title":"J Clin Epidemiol"},{"key":"1023_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ejca.2010.11.004","volume":"47","author":"LV van de Poll-Franse","year":"2011","unstructured":"van de Poll-Franse LV, Mols F, Gundy CM, Creutzberg CL, Nout RA, Verdonck-de Leeuw IM, et al. Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population. Eur J Cancer. 2011;47:667\u201375.","journal-title":"Eur J Cancer"},{"key":"1023_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1200\/JCO.2010.28.0107","volume":"29","author":"K Cocks","year":"2011","unstructured":"Cocks K, King MT, Velikova G, Martyn St-James M, Fayers PM, Brown JM. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol. 2011;29:89\u201396.","journal-title":"J Clin Oncol"},{"key":"1023_CR28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1080\/0284186X.2016.1266089","volume":"56","author":"V Arndt","year":"2017","unstructured":"Arndt V, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, et al. Quality of life in long-term and very long-term cancer survivors versus population controls in Germany. Acta Oncol. 2017;56:190\u20137.","journal-title":"Acta Oncol"},{"key":"1023_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11764-014-0419-6","volume":"9","author":"FJ Drummond","year":"2015","unstructured":"Drummond FJ, Kinnear H, O'Leary E, et al. Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study. J Cancer Surviv. 2015;9:361\u201372.","journal-title":"J Cancer Surviv"},{"key":"1023_CR30","doi-asserted-by":"publisher","unstructured":"Hsu T, Ennis M, Hood N, Graham M, Goodwin PJ. Quality of life in long-term breast cancer survivors. J Clin Oncol. 2013;31:3540\u20138. https:\/\/doi.org\/10.1200\/JCO.2012.48.1903.","DOI":"10.1200\/JCO.2012.48.1903"},{"key":"1023_CR31","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1200\/JCO.2016.68.5826","volume":"35","author":"MC Janelsins","year":"2017","unstructured":"Janelsins MC, Heckler CE, Peppone LJ, Kamen C, Mustian KM, Mohile SG, et al. Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls: an analysis from a nationwide, multicenter, prospective longitudinal study. J Clin Oncol. 2017;35:506\u201314.","journal-title":"J Clin Oncol"},{"key":"1023_CR32","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1186\/s12885-017-3793-4","volume":"17","author":"Y Zeng","year":"2017","unstructured":"Zeng Y, Cheng ASK, Song T, Sheng X, Zhang Y, Liu X, et al. Subjective cognitive impairment and brain structural networks in Chinese gynaecological cancer survivors compared with age-matched controls: a cross-sectional study. BMC Cancer. 2017;17:796.","journal-title":"BMC Cancer"},{"key":"1023_CR33","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/bjh.14211","volume":"174","author":"AM Williams","year":"2016","unstructured":"Williams AM, Zent CS, Janelsins MC. What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research. Br J Haematol. 2016;174:835\u201346.","journal-title":"Br J Haematol"},{"key":"1023_CR34","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10549-019-05149-4","volume":"175","author":"ML Gregorowitsch","year":"2019","unstructured":"Gregorowitsch ML, Ghedri A, Young-Afat DA, et al. The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients. Breast Cancer Res Treat. 2019;175:429\u201341.","journal-title":"Breast Cancer Res Treat"},{"key":"1023_CR35","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s11764-017-0656-6","volume":"12","author":"HM Dhillon","year":"2018","unstructured":"Dhillon HM, Tannock IF, Pond GR, Renton C, Rourke SB, Vardy JL. Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy. J Cancer Surviv. 2018;12:178\u201385.","journal-title":"J Cancer Surviv"},{"key":"1023_CR36","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2147\/NDT.S200501","volume":"15","author":"P Jarzemski","year":"2019","unstructured":"Jarzemski P, Brzoszczyk B, Popiolek A, et al. Cognitive function, depression, and anxiety in patients undergoing radical prostatectomy with and without adjuvant treatment. Neuropsychiatr Dis Treat. 2019;15:819\u201329.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1023_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41523-018-0076-4","volume":"4","author":"K Van Dyk","year":"2018","unstructured":"Van Dyk K, Bower JE, Crespi CM, et al. Cognitive function following breast cancer treatment and associations with concurrent symptoms. NPJ Breast Cancer. 2018;4:25.","journal-title":"NPJ Breast Cancer"},{"key":"1023_CR38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1188\/15.CJON.19-01AP","volume":"19","author":"D Von Ah","year":"2015","unstructured":"Von Ah D. Cognitive changes associated with cancer and cancer treatment: state of the science. Clin J Oncol Nurs. 2015;19:47\u201356.","journal-title":"Clin J Oncol Nurs"},{"key":"1023_CR39","doi-asserted-by":"crossref","unstructured":"Mayo SJ, Lustberg M, Dhillon HM. et al, Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group. Support Care Cancer. 2020.","DOI":"10.1007\/s00520-020-05860-9"},{"key":"1023_CR40","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1007\/s00520-019-04694-4","volume":"27","author":"C Cormio","year":"2019","unstructured":"Cormio C, Caporale F, Spatuzzi R, Lagattolla F, Lisi A, Graziano G. Psychosocial distress in oncology: using the distress thermometer for assessing risk classes. Support Care Cancer. 2019;27:4115\u201321.","journal-title":"Support Care Cancer"},{"key":"1023_CR41","first-page":"175","volume":"10","author":"KK Ownby","year":"2019","unstructured":"Ownby KK. Use of the distress thermometer in clinical practice. J Adv Pract Oncol. 2019;10:175\u20139.","journal-title":"J Adv Pract Oncol"},{"key":"1023_CR42","first-page":"32","volume":"7","author":"LSJ Wagner","year":"2009","unstructured":"Wagner LSJ, Butt Z, Lao J, Cella D. Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy-cognitive function instrument. J Support Oncol. 2009;7:32\u20139.","journal-title":"J Support Oncol"},{"key":"1023_CR43","doi-asserted-by":"publisher","first-page":"dju186","DOI":"10.1093\/jnci\/dju186","volume":"106","author":"SM Castellino","year":"2014","unstructured":"Castellino SM, Ullrich NJ, Whelen MJ, Lange BJ. Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors. J Natl Cancer Inst. 2014;106:dju186.","journal-title":"J Natl Cancer Inst"},{"key":"1023_CR44","doi-asserted-by":"publisher","first-page":"e13088","DOI":"10.1111\/ecc.13088","volume":"28","author":"PJC van Lonkhuizen","year":"2019","unstructured":"van Lonkhuizen PJC, Klaver KM, Wefel JS, et al. Interventions for cognitive problems in adults with brain cancer: a narrative review. Eur J Cancer Care (Engl). 2019;28:e13088.","journal-title":"Eur J Cancer Care (Engl)"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-021-01023-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-021-01023-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-021-01023-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T13:38:33Z","timestamp":1648561113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-021-01023-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,17]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1023"],"URL":"https:\/\/doi.org\/10.1007\/s11764-021-01023-9","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,17]]},"assertion":[{"value":"29 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the questionnaire and methodology was locally obtained for all study samples separately.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable (consent statement regarding publishing an individual\u2019s data or image)","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}